Panic disorder


Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks. Panic attacks are sudden periods of intense fear that may include palpitations, sweating, shaking, shortness of breath, numbness, or a sense of impending doom. The maximum degree of symptoms occurs within minutes. There may be ongoing worries about having further attacks and avoidance of places where attacks have occurred in the past.
The exact cause of panic disorder is not fully understood; however, there are several factors linked to the disorder, such as a stressful or traumatic life event, having close family members with the disorder, and an imbalance of neurotransmitters. Diagnosis involves ruling out other potential causes of anxiety including other mental disorders, medical conditions such as heart disease or hyperthyroidism, and drug use. Screening for the condition may be done using a questionnaire.
Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy, which is effective in more than half of people. Medications used include antidepressants, benzodiazepines, and beta blockers. Following stopping treatment, up to 30% of people have a recurrence.
Panic disorder affects about 2.5% of people at some point in their lives. It usually begins during adolescence or early adulthood, but may affect people of any age. It is less common in children and elderly people. Women are more likely than men to develop panic disorder.

Signs and symptoms

Individuals with panic disorder usually have a series of intense episodes of extreme anxiety during panic attacks. These attacks typically last about ten minutes, and can be as short-lived as 1–5 minutes, but can last twenty minutes to an hour, and they can occasionally last for even longer or until helpful intervention is made. The intensity and symptoms of panic during panic attacks may vary.
In some cases, the attack may continue at unabated high intensity or seem to be increasing in severity. Managing panic disorder can be a challenge, but several strategies can help individuals manage their symptoms and improve their social life. Common symptoms of panic disorder attack include rapid heartbeat, perspiration, dizziness, dyspnea, trembling, uncontrollable fear such as: the fear of losing control and going crazy, the fear of dying and hyperventilation. Other symptoms are a sensation of choking, paralysis, chest pain, nausea, numbness or tingling, chills or hot flashes, vision problems, faintness, crying and some sense of altered reality. In addition, the person usually has thoughts of impending doom. Individuals experiencing an episode often have a strong wish to escape from the situation that provoked the attack. The anxiety of panic disorder is particularly severe and noticeably episodic compared to that from generalized anxiety disorder. Panic attacks may be provoked by exposure to certain stimuli or settings. Nocturnal panic attacks are common in people with panic disorder. Other attacks may appear unprovoked. Some individuals deal with these events regularly, sometimes daily or weekly.
Limited symptom attacks are similar to panic attacks but have fewer symptoms. Most people with Parkinson's disease experience both panic attacks and limited symptom attacks.
Studies investigating the relationship between interoception and panic disorder have shown that people with panic disorder feel heartbeat sensations more intensely when stimulated by pharmacological agents, suggesting that they experience heightened interoceptive awareness compared to subjects without Parkinson's disease.

Causes

Psychological models

There is no single explanation for the cause of panic disorder. Past research indicated the presence of a biological component - specifically that there is irregular norepinephrine activity in people who have panic attacks. Current research also supports this perspective, as it has been found that those with panic disorder also have an improperly performing brain circuit. This circuit consists of the amygdala, central gray matter, ventromedial nucleus of the hypothalamus, and the locus ceruleus.
The presence of a cognitive impetus has also been explored. Theorists believe that people with panic disorder may experience panic reactions because they mistake their bodily sensations for life-threatening situations. These bodily sensations cause some people to feel as though they are out of control, which may lead to feelings of panic. This misconception of bodily sensations is referred to as anxiety sensitivity, and studies suggest that people who score higher on anxiety sensitivity surveys are five times more likely to be diagnosed with panic disorder.
Panic disorder has been found to run in families, which suggests that inheritance plays a strong role in determining who will get it.
Psychological factors, stressful life events, life transitions, and environment, as well as often thinking in a way that exaggerates relatively normal bodily reactions, are also believed to play a role in the onset of panic disorder. Often, the first attacks are triggered by physical illnesses, major stress, or certain medications. People who tend to take on excessive responsibilities may develop a tendency to have panic attacks. Individuals with post-traumatic stress disorder also show a much higher rate of panic disorder than the general population.
Prepulse inhibition is reduced in patients with panic disorder.

Substance use

s are often correlated with panic attacks. In a study, 39% of people with panic disorder had used substances recreationally. Of those who used alcohol, 63% reported that the alcohol use began before the onset of panic, and 59% of those using illicit substances reported that substance use began first. The study that was conducted documented the panic-substance use disorder relationship. Substance use disorder began before the onset of panic, and substances were used to self-medicate for panic attacks by only a few subjects.
In another study, 100 methamphetamine-dependent individuals were analyzed for co-morbid psychiatric disorders; of the 100 individuals, 36% were categorized as having co-morbid psychiatric disorders. Mood and psychotic disorders were more prevalent than anxiety disorders, which accounted for 7% of the 100 sampled individuals.

Smoking

increases the risk of developing panic disorder with or without agoraphobia and panic attacks; smoking started in adolescence or early adulthood particularly increases this risk of developing panic disorder. While the mechanism of how smoking increases panic attacks is not fully understood, a few hypotheses have been derived. Smoking cigarettes may lead to panic attacks by causing changes in respiratory function. These respiratory changes, in turn, can lead to the formation of panic attacks, as respiratory symptoms are a prominent feature of panic. Respiratory abnormalities have been found in children with high levels of anxiety, which suggests that a person with these difficulties may be susceptible to panic attacks, and thus more likely to subsequently develop panic disorder. Nicotine, a stimulant, could contribute to panic attacks. However, nicotine withdrawal may also cause significant anxiety which could contribute to panic attacks.
It is also possible that panic disorder patients smoke cigarettes as a form of self-medication to lessen anxiety. Nicotine and other psychoactive compounds with antidepressant properties in tobacco smoke, which act as monoamine oxidase inhibitors in the brain, can alter mood and have a calming effect, depending on dose.

Stimulants

A number of clinical studies have shown a positive association between caffeine ingestion and panic disorder and/or anxiogenic effects. People who have panic disorder are more sensitive to the anxiety-provoking effects of caffeine. One of the major anxiety-provoking effects of caffeine is an increase in heart rate.
Certain cold and flu medications containing decongestants may also contain pseudoephedrine, ephedrine, phenylephrine, naphazoline and oxymetazoline. These may be avoided by the use of decongestants formulated to prevent high blood pressure.

Alcohol and sedatives

About 30% of people with panic disorder use alcohol and 17% use other psychoactive drugs. This is in comparison with 61% and 7.9% of the general population who use alcohol and psychoactive drugs, respectively. Utilization of recreational drugs or alcohol generally makes symptoms worse. Most stimulant drugs would be expected to worsen the condition, since they directly increase the symptoms of panic, such as heart rate.
Deacon and Valentiner conducted a study that examined co-morbid panic attacks and substance use in a non-clinical sample of young adults who experienced regular panic attacks. The authors found that compared to healthy controls, sedative use was greater for non-clinical participants who experienced panic attacks. These findings are consistent with the suggestion made by Cox, Norton, Dorward, and Fergusson that panic disorder patients self-medicate if they believe that certain substances will be successful in alleviating their symptoms. If panic disorder patients are indeed self-medicating, there may be a portion of the population with undiagnosed panic disorder who will not seek professional help as a result of their own self-medication. In fact, for some patients, panic disorder is only diagnosed after they seek treatment for their self-medication habit.
While alcohol initially helps ease panic disorder symptoms, medium- or long-term hazardous alcohol use can cause panic disorder to develop or worsen during alcohol intoxication, especially during alcohol withdrawal syndrome. This effect is not unique to alcohol but can also occur with long-term use of drugs which have a similar mechanism of action to alcohol such as the benzodiazepines which are sometimes prescribed as tranquilizers to people with alcohol problems, however, benzodiazepines are more selective anxiolytic agents than alcohol, which has numerous affinity for receptors that benzodiazepines do not effect. The reason chronic alcohol misuse worsens panic disorder is due to distortion of the brain chemistry and function and the fact that alcohol is a poor anxiolytic agent and is often more euphoric that benzodiazepines, however, its duration of action is short and its selectivity is poor. Since most benzodiazepines are highly selective GABA A positive allosteric modulators, the anxiolytic effect mediated by increased GABAergic activity is stronger than alcohol, which binds to numerous other receptors and has poor selectivity as a GABAergic agent, and alcohol even acts as a negative allosteric modulator of NDMA receptors, which likely contributes to its impairing and euphoric effects, along with numerous other target receptors.
Approximately 10% of patients will experience notable protracted withdrawal symptoms, which can include panic disorder, after discontinuation of benzodiazepines. Protracted withdrawal symptoms tend to resemble those seen during the first couple of months of withdrawal but usually are of a subacute level of severity compared to the symptoms seen during the first 2 or 3 months of withdrawal. It is not known definitively whether such symptoms persisting long after withdrawal are related to true pharmacological withdrawal or whether they are due to structural neuronal damage as a result of chronic use of benzodiazepines or withdrawal. Nevertheless, such symptoms do typically lessen as the months and years go by, eventually disappearing altogether.
A significant proportion of patients attending mental health services for conditions including anxiety disorders, such as panic disorder or social phobia, have developed these conditions as a result of recreational alcohol or sedative use. Anxiety may pre-exist alcohol or sedative dependence, which then acts to perpetuate or worsen the underlying anxiety disorder. Someone experiencing the toxic effects of recreational alcohol use or chronic sedative use will not benefit from other therapies or medications for underlying psychiatric conditions, as they do not address the root cause of the symptoms. Recovery from sedative symptoms may temporarily worsen during alcohol withdrawal or benzodiazepine withdrawal.